Protagonist Therapeutics to rake sin $22 mln

Newark, California-based Protagonist Therapeutics, a biopharmaceutical company, has agreed to sell 2.75 million shares for $22 million. The investors included BVF Partners LP. The deal is expected to close on August 8, 2018.

DealsNorth AmericaUSHealthcareBriefs